Načítá se...
The emerging potential for network analysis to inform precision cancer medicine
Precision cancer medicine promises to tailor clinical decisions to patients using genomic information. Indeed, successes of drugs targeting genetic alterations in tumors, such as imatinib that targets BCR-ABL in chronic myelogenous leukemia, have demonstrated the power of this approach. However biol...
Uloženo v:
| Vydáno v: | J Mol Biol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097914/ https://ncbi.nlm.nih.gov/pubmed/29908887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmb.2018.06.016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|